Home > Financial Ratios > KWALITY PHARMACEUTICALS

KWALITY PHARMACEUTICALS
Core EBITDA Growth

    Back to All Ratios
KWALITY PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for KWALITY PHARMACEUTICALS
Please provide your vote to see the results

KWALITY PHARMACEUTICALS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 20.797.03-63.65475.4870.50

What is the latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS ?

The latest Core EBITDA Growth ratio of KWALITY PHARMACEUTICALS is 20.79 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202520.79
Mar20247.03
Mar2023-63.65
Mar2022475.48
Mar202170.50

How is Core EBITDA Growth of KWALITY PHARMACEUTICALS Trending?

Years Core EBITDA Growth % Change
Mar2025 20.79
195.73
Mar2024 7.03
Positive
Mar2023 -63.65
Negative
Mar2022 475.48
574.44
Mar2021 70.5 -

Other Financial Ratios of KWALITY PHARMACEUTICALS


Compare Core EBITDA Growth ratio of peers of KWALITY PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS ₹944.5 Cr -4.9% 0.4% 4.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹433,044.0 Cr 1.5% 6.5% -1.5% Stock Analytics
DIVIS LABORATORIES ₹172,877.0 Cr 0.8% 0.3% 6.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹127,042.0 Cr 1% 4.4% 18.1% Stock Analytics
CIPLA ₹123,060.0 Cr -0.4% -3.8% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹104,190.0 Cr 0.1% -2.8% 1.8% Stock Analytics


KWALITY PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
KWALITY PHARMACEUTICALS

-4.9%

0.4%

4.1%

SENSEX

0.5%

1.7%

11%


You may also like the below Video Courses